X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (29) 29
index medicus (25) 25
male (18) 18
aged (15) 15
female (13) 13
oncology (12) 12
middle aged (11) 11
adult (8) 8
chemotherapy (8) 8
double-blind method (8) 8
care and treatment (7) 7
docetaxel (6) 6
survival analysis (6) 6
abridged index medicus (5) 5
analysis (5) 5
clinical trials (5) 5
medicine, general & internal (5) 5
patients (5) 5
prognosis (5) 5
stroke (5) 5
treatment outcome (5) 5
aged, 80 and over (4) 4
antineoplastic agents - therapeutic use (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
article (4) 4
australia (4) 4
cancer (4) 4
colorectal cancer (4) 4
genetics & heredity (4) 4
management (4) 4
neoplasm metastasis (4) 4
open-label (4) 4
prostate cancer (4) 4
prostatic neoplasms, castration-resistant - drug therapy (4) 4
quality of life (4) 4
risk factors (4) 4
survival (4) 4
abiraterone acetate (3) 3
anticoagulants (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
biochemistry & molecular biology (3) 3
cancer therapies (3) 3
cell biology (3) 3
clinical medicine (3) 3
clinical neurology (3) 3
disease-free survival (3) 3
enzalutamide (3) 3
expression (3) 3
gene-expression (3) 3
hemorrhage (3) 3
immunotherapy (3) 3
life sciences (3) 3
magnetic resonance imaging (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
metastasis (3) 3
mitoxantrone (3) 3
plus prednisone (3) 3
prednisone (3) 3
proportional hazards models (3) 3
prostatic neoplasms, castration-resistant - pathology (3) 3
research (3) 3
risk (3) 3
safety (3) 3
surgery (3) 3
taxoids - therapeutic use (3) 3
trial (3) 3
acute ischemic-stroke (2) 2
algorithms (2) 2
animals (2) 2
antibodies (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic agents - adverse effects (2) 2
antithrombotic therapy (2) 2
aspirin (2) 2
base sequence (2) 2
biotechnology & applied microbiology (2) 2
cancer patients (2) 2
carcinoma (2) 2
cardiovascular diseases (2) 2
cells (2) 2
cetuximab (2) 2
classification (2) 2
clinical-trials (2) 2
colony-stimulating factor (2) 2
colorectal neoplasms - mortality (2) 2
colorectal neoplasms - pathology (2) 2
combination (2) 2
compassionate-use program (2) 2
cyp17 (2) 2
cystic fibrosis - immunology (2) 2
cystic fibrosis - pathology (2) 2
cytotoxicity (2) 2
diarrhea - chemically induced (2) 2
disease (2) 2
dogs - genetics (2) 2
events (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 7, pp. 700 - 712
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2013, Volume 368, Issue 2, pp. 138 - 148
Journal Article
Proceedings of the National Academy of Sciences, ISSN 0027-8424, 12/2019, Volume 116, Issue 49, pp. 24840 - 24851
Huntington’s disease (HD) is a chronic neurodegenerative disorder characterized by a late clinical onset despite ubiquitous expression of the mutant Huntingtin... 
Life Sciences | Neurons and Cognition
Journal Article
by Petrylak, Daniel and Petrylak, Daniel P and de Wit, Ronald and Chi, Kim Nguyen and Chi, Kim N and Drakaki, Alexandra and Sternberg, Cora N and Nishiyama, Hiroyuki and Castellano, Daniel and Hussain, Syed and Fléchon, Aude and Bamias, Aristotelis and Yu, Evan Y and van der Heijden, Michiel S and Matsubara, Nobuaki and Alekseev, Boris and Necchi, Andrea and Géczi, Lajos and Ou, Yen-Chuan and Coskun, Hasan Senol and Su, Yu-Li and Su, Wen-Pin and Hegemann, Miriam and Percent, Ivor and Percent, Ivor J and Lee, Yun-Gyoo and Lee, Hyo Jin and Lee, Jae-Lyun and Tucci, Marcello and Semenov, Andrey and Laestadius, Fredrik and Peer, Avivit and Tortora, Giampaolo and Safina, Sufia Z and Safina, Sufia and del Muro, Xavier Garcia and Rodriguez-Vida, Alejo and Cicin, Irfan and Harputluoglu, Hakan and Widau, Ryan C and Liepa, Astra M and Walgren, Richard A and Hamid, Oday and Zimmermann, Annamaria H and Bell-McGuinn, Katherine M and Powles, Thomas and Wong, Suet-Lai Shirley and Tan, Thean Hsiang and Hovey, Elizabeth Jane and Clay, Timothy Dudley and Ng, Siobhan Su Wan and Rutten, Annemie and Machiels, Jean-Pascal and Dumez, Herlinde and Cheng, Susanna Yee-Shan and Ferrario, Cristiano and Sengeloev, Lisa and Jensen, Niels Viggo and Thibault, Constance and Laguerre, Brigitte and Joly, Florence and Flechon, Aude and Culine, Stéphane and Becht, Catherine and Niegisch, Günter and Stöckle, Michael and Grimm, Marc-Oliver and Gakis, Georgios and Schultze-Seemann, Wolfgang and Kalofonos, Haralambos and Mavroudis, Dimitrios and Papandreou, Christos and Karavasilis, Vasilis and Révész, Janos and Geczi, Lajos and Rosenbaum, Eli and Leibowitz-Amit, Raya and Kejzman, Daniel and Sarid, David and Scagliotti, Giorgio Vittorio and Bracarda, Sergio and Massari, Francesco and Osawa, Takahiro and Miyajima, Naoto and Shinohara, Nobuo and Fukuta, Fumimasa and Ohyama, Chikara and Obara, Wataru and Yamashita, Shinichi and Tomita, Yoshihiko and Kawai, Koji and Fukasawa, Satoshi and Oyama, Masafumi and Yonese, Junji and Nagata, Masayoshi and Uemura, Motohide and Nishimura, Kazuo and Kawakita, Mutsushi and Tsunemori, Hiroyuki and Hashine, Katsuyoshi and ... and RANGE Study Investigators and RANGE study investigators
The Lancet, ISSN 0140-6736, 11/2017, Volume 390, Issue 10109, pp. 2266 - 2277
Few treatments with a distinct mechanism of action are available for patients with platinum-refractory advanced or metastatic urothelial carcinoma. We assessed... 
BREAST-CANCER | BLADDER-CANCER | LUNG-CANCER | 2ND-LINE THERAPY | TRANSITIONAL-CELL-CARCINOMA | FOLLOW-UP | OPEN-LABEL | FACTOR RECEPTOR-2 | II TRIAL | ENDOTHELIAL GROWTH-FACTOR | MEDICINE, GENERAL & INTERNAL | CISPLATIN | DOXORUBICIN | METHOTREXATE | VINBLASTINE | COMBINATION | Carcinoma, Transitional Cell - mortality | Prognosis | Humans | Middle Aged | Male | Neoplasm Invasiveness - pathology | Urinary Bladder Neoplasms - pathology | Adult | Female | Urinary Bladder Neoplasms - mortality | Double-Blind Method | Risk Assessment | Docetaxel | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Urinary Bladder Neoplasms - drug therapy | Disease-Free Survival | Taxoids - administration & dosage | Carcinoma, Transitional Cell - pathology | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Internationality | Neoadjuvant Therapy - methods | Carcinoma, Transitional Cell - drug therapy | Survival Analysis | Aged | Neoplasm Staging | Antimitotic agents | Care and treatment | Carcinoma | Analysis | Clinical trials | Product development | Metastasis | Antineoplastic agents | Cancer | Cytotoxicity | Oncology | Patients | Cancer therapies | Metastases | Angiogenesis | Chemotherapy | Platinum | Medical prognosis | Ligands | Clinical medicine | Urothelial carcinoma | Vascular endothelial growth factor | Apoptosis
Journal Article
British Journal of Ophthalmology, ISSN 0007-1161, 12/2017, Volume 101, Issue 12, pp. 1679 - 1682
Journal Article
Rheumatology, ISSN 1462-0324, 04/2018, Volume 57, Issue suppl_3
Journal Article
Journal Article
by Al-Shahi Salman, Rustam and Minks, David P and Minks, David and Mitra, Dipayan and Rodrigues, Mark A and Bhatnagar, Priya and du Plessis, Johannes and du Plessis, Johann C and Joshi, Yogish and Dennis, Martin S and Dennis, Martin and Murray, Gordon D and Newby, David E and Sandercock, Peter A G and Sprigg, Nikola and Stephen, Jacqueline and Sudlow, Cathie and Sudlow, Cathie L M and Werring, David and Werring, David J and Whiteley, William N and Whiteley, William and Wardlaw, Joanna M and White, Julie and White, Philip M and White, James and White, Susan and Baigent, Colin and Lasserson, Daniel and Sullivan, Frank and Carrie, Johanna and Rojas, Javier and Amoils, Shannon and Bamford, John and Armitage, Jane and Rinkel, Gabriel and Lowe, Gordon and Emberson, Jonathan and Innes, Karen and Dinsmore, Lynn and Drever, Jonathan and Williams, Rebecca and Williams, Carol and Perry, David and Perry, Jack and McGill, Connor and Buchanan, David and Walker, Susannah and Walker, Marion and Walker, Pauli and Walker, Allan and Hutchison, Aidan and Matthews, Christopher and Fraser, Ruth and McGrath, Aileen and Deary, Ann and Anderson, Rosemary and Hansen, Christian and Parker, Richard and Rodriguez, Aryelly and Macleod, Malcolm and Gattringer, Thomas and Palmer, Jeb and Sakka, Eleni and Adil-Smith, Jennifer and Lerpiniere, Christine and O'Brien, Eoin and O'Brien, Richard and Burgess, Seona and Burgess, Laura and Mead, Denise and Mead, Gillian and Paulton, Ruth and Doubal, Fergus and McCormick, Katrina and Hunter, Neil and Hunter, Annemarie and Taylor, Vicky and Taylor, Pat and Parakramawansha, Ruwan and Blair, Caroline and Blair, Gordon and MacRaild, Allan and Parry-Jones, Adrian and Johnes, Mary and Lee, Stephanie and Shaw, Louise and Shaw, Kelly Marie and Burger, Ilse and Punter, Martin and Ingham, Andrea and Perez, Jane and Naing, Zin and Morell, Jordi and Marsden, Tracy and Hall, Andrea and Marshall, Sally and Harrison, Thomas and Harrison, Melanie and Harrison, Louise and ... and RESTART Collaboration
The Lancet Neurology, ISSN 1474-4422, 07/2019, Volume 18, Issue 7, pp. 643 - 652
Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared... 
MICROBLEEDS | SUPERFICIAL SIDEROSIS | SIGNS | AMYLOID ANGIOPATHY | ACUTE ISCHEMIC-STROKE | ANTITHROMBOTIC THERAPY | ASPIRIN | CLINICAL NEUROLOGY | Atrophy | Neuroimaging | Anticoagulants | Stroke | Aspirin | Statistical analysis | Medical imaging | Magnetic resonance imaging | Computed tomography | Biomarkers | Hemorrhage
Journal Article